Genetic variant linked with increased risk of anthracycline-related cardiomyopathy

In results published in the Journal of Clinical Oncology, researchers from the University of Alabama at Birmingham discovered an association between the genetic variant ROBO2 and an increased risk of developing anthracycline-related cardiomyopathy.

Read more: https://www.uab.edu/news/research/item/13334-genetic-variant-linked-with-increased-risk-of-anthracycline-related-cardiomyopathy